• Washington University School of Law, J.D.; Order of the Coif; Order of the Barristers; Editor-At-Large, Washington University Law Quarterly;
  Washington University School of Medicine, Ph.D., Molecular Genetics;
  Franklin and Marshall College, B.A., Biology, cum laude; Phi Beta Kappa Honor Society.

• Former Associate at Fish & Richardson, P.C.

Natalie is a fourth year associate whose practice emphasizes general client counseling and the protection of innovation through strategic patent filings and prosecution in the biotechnology, molecular biology and pharmaceutical sectors.

A Bigger Picture:

Natalie's experience includes drafting patent applications, devising prosecution strategies, managing U.S. and foreign prosecution for patent portfolios, and due diligence and freedom to operate analyses in the fields of biochemistry, molecular biology, immunology, pharmaceuticals, and genetics.

Before joining LL&A, Natalie was an associate in the Boston office of Fish & Richardson, P.C., where she was a member of the Life Science Prosecution Practice Group. She is registered to practice before the United States Patent and Trademark Office, and is a member of the Massachusetts Bar.

While in law school, Natalie worked part time in the patent department of the Pharmacia Corporation, where she gained experience in freedom to operate and validity analyses, and developed product out-licensing packages.  She served as Editor-At-Large for the Washington University Law Quarterly, and participated in the AIPLA Giles Sutherland Rich Memorial Moot Court Competition, in which she and her partner earned the award of Best Appellant Brief for the Midwest region. Natalie was a member of the Order of the Coif (an honorary scholastic society for students who graduate in the top 10% of their class) and Order of the Barristers (an honorary society for excellence in lawyering skills).

Before law school, Natalie obtained her Ph.D. in Molecular Genetics from the Washington University School of Medicine in St. Louis, MO. Her graduate lab was in the Howard Hughes Medical Institute and in the Division of Molecular Oncology. Her research employed techniques and concepts from the fields of molecular genetics, molecular biology, immunology, and biochemistry to explore the role of the cell cycle in regulating T cell apoptosis, focusing primarily on the roles of the retinoblastoma gene product (pRb), E2F1, and p73. She was also involved in developing a TAT-mediated protein transduction methodology. Her thesis was titled “Cell Cycle Regulation of T Cell Receptor Activation-Induced Cell Death.” Her publications include articles in Nature and Immunity.

After college and prior to starting her graduate work, Natalie gained research experience working as a research technician in the Department of Medical Oncology at Fox Chase Cancer Center in Philadelphia, PA, where her studies focused on identifying genes that are over-expressed in patients with malignant mesothelioma.

Natalie enjoys skiing, traveling, and spending time outdoors.